1016 All-Oral 12-Week Combination Treatment With Daclatasvir (DCV) and Sofosbuvir (SOF) in Treatment-Experienced Patients Infected With HCV Genotype (GT) 3: A Subanalysis of the Ally-3 Phase 3 Study

1016 All-Oral 12-Week Combination Treatment With Daclatasvir (DCV) and Sofosbuvir (SOF) in Treatment-Experienced Patients Infected With HCV Genotype (GT) 3: A Subanalysis of the Ally-3 Phase 3 Study

Saved in:
Bibliographic Details
Published in:Gastroenterology (New York, N.Y. 1943) Vol. 148; no. 4; p. S-1003
Main Authors: Nelson, David, Bernstein, David, Freilich, Bradley, Lawitz, Eric, Hawkins, Trevor, Pockros, Paul J, Thuluvath, Paul J, Younes, Ziad H, Bennett, Michael, Ghalib, Reem, Ruane, Peter J, Tong, Myron J, Bhore, Rafia, Yin, Philip D, Noviello, Stephanie, Rana, Khurram
Format: Journal Article
Language:English
Published: Elsevier Inc 01-04-2015
Subjects:
Gastroenterology and Hepatology
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
ISSN:0016-5085
1528-0012
DOI:10.1016/S0016-5085(15)33422-3